These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 389509

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hemolytic uremic syndrome with hypocomplementemia, serum C3NeF, and glomerular deposits of C3.
    Barré P, Kaplan BS, de Chadarévian JP, Drummond KN.
    Arch Pathol Lab Med; 1977 Jul; 101(7):357-61. PubMed ID: 577389
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Renal histopathology in the hemolytic-uremic syndrome following shigellosis.
    Koster FT, Boonpucknavig V, Sujaho S, Gilman RH, Rahaman MM.
    Clin Nephrol; 1984 Feb; 21(2):126-33. PubMed ID: 6373079
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Late recovery of renal function in a woman with the hemolytic uremic syndrome.
    Ponticelli C, Maestri O, Imbasciati E, Brancaccio D, Rossi E.
    Clin Nephrol; 1977 Aug; 8(2):367-70. PubMed ID: 891050
    [Abstract] [Full Text] [Related]

  • 7. [Hemolytic uremic syndrome in adults].
    Hertig A, Ridel C, Rondeau E.
    Nephrol Ther; 2010 Jul; 6(4):258-71. PubMed ID: 20399168
    [Abstract] [Full Text] [Related]

  • 8. Follow-up of kidney graft recipients with cyclosporine-associated hemolytic-uremic syndrome and thrombotic microangiopathy.
    Bren A, Pajek J, Grego K, Buturovic J, Ponikvar R, Lindic J, Knap B, Vizjak A, Ferluga D, Kandus A.
    Transplant Proc; 2005 May; 37(4):1889-91. PubMed ID: 15919494
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pathophysiology and management of thrombotic microangiopathies.
    Ruggenenti P, Remuzzi G.
    J Nephrol; 1998 May; 11(6):300-10. PubMed ID: 10048496
    [Abstract] [Full Text] [Related]

  • 12. [Hemolytic-uremic syndrome in the adult (author's transl)].
    Montoliu J, Darnell A, Torras A, Botey A, Revert L.
    Med Clin (Barc); 1980 Jan 10; 74(1):5-10. PubMed ID: 7351870
    [Abstract] [Full Text] [Related]

  • 13. Postpartum renal failure and the hemolytic-uremic syndrome.
    Meadows R, Lawrence JR.
    Perspect Nephrol Hypertens; 1973 Jan 10; 1 Pt 2(0):1061-7. PubMed ID: 4547839
    [No Abstract] [Full Text] [Related]

  • 14. The renal manifestations and outcome of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in adults.
    Conlon PJ, Howell DN, Macik G, Kovalik EC, Smith SR.
    Nephrol Dial Transplant; 1995 Jan 10; 10(7):1189-93. PubMed ID: 7478122
    [Abstract] [Full Text] [Related]

  • 15. [A case of hemolytic-uremic syndrome after normal pregnancy and delivery. Two year follow-up observations].
    Muszytowski M, Trafny R, Wojnicz M, Ruszkiewicz-Fołda M.
    Przegl Lek; 1996 Jan 10; 53(5):459-60. PubMed ID: 8754413
    [Abstract] [Full Text] [Related]

  • 16. [Renal biopsy in the hemolytic-uremic syndrome in infancy. A study of three cases (author's transl)].
    Fernández-Sanz J, Galera H, Armas JR, Matilla A, Nogales F.
    Med Clin (Barc); 1980 Jan 25; 74(2):48-51. PubMed ID: 7366264
    [Abstract] [Full Text] [Related]

  • 17. Hemolytic uremic syndrome in patients with Behçet's disease treated with cyclosporin A: report of 2 cases.
    Beaufils H, de Groc F, Gubler MC, Wechsler B, Le Hoang P, Baumelou A, Chomette G, Jacobs C.
    Clin Nephrol; 1990 Oct 25; 34(4):157-62. PubMed ID: 2257701
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Renal thrombotic microangiopathies induced by severe hypertension.
    Zhang B, Xing C, Yu X, Sun B, Zhao X, Qian J.
    Hypertens Res; 2008 Mar 25; 31(3):479-83. PubMed ID: 18497467
    [Abstract] [Full Text] [Related]

  • 20. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.
    Morigi M, Galbusera M, Gastoldi S, Locatelli M, Buelli S, Pezzotta A, Pagani C, Noris M, Gobbi M, Stravalaci M, Rottoli D, Tedesco F, Remuzzi G, Zoja C.
    J Immunol; 2011 Jul 01; 187(1):172-80. PubMed ID: 21642543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.